Evgenii A. Beloborodov
Ulyanovsk, ULY, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Biodistribution of the Bombesin Receptor-Targeted Radiopharmaceutical Precursor BBN/C1-C2 in a Prostate Cancer Model.
Journal: Sovremennye tekhnologii v meditsine
Published: October 28, 2024
Stabilizing Scaffold for Short Peptides Based on Knottins.
Journal: Current cancer drug targets
Published: October 03, 2023
Development and Synthesis of Bombesin-Based Radiopharmaceutical Precursors Modified with Knottin.
Journal: Sovremennye tekhnologii v meditsine
Published: September 26, 2023
Protective Effect of Peptide Calcium Channel Blocker Omega-Hexatoxin-Hv1a on Epithelial Cell during Ischemia-Reperfusion Injury.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 11, 2023
Peptide Sodium Channels Modulator Mu-Agatoxin-Aa1a Prevents Ischemia-Reperfusion Injury of Cells.
Journal: Molecules (Basel, Switzerland)
Published: March 14, 2023
Effect of the Peptide Calcium Channel Blocker ω-hexatoxin-Hv1a on Cell Death during Ischemia/Reperfusion in vitro.
Journal: Sovremennye tekhnologii v meditsine
Published: November 24, 2022
The effect of chromosome abnormalities on expression of SnoRNA in radioresistant and radiosensitive cell lines after irradiation.
Journal: Cancer biomarkers : section A of Disease markers
Published: March 11, 2022
Arthropod toxins inhibiting Ca2+ and Na+ channels prevent AC-1001 H3 peptide-induced apoptosis.
Journal: Journal of peptide science : an official publication of the European Peptide Society
Published: February 28, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026